Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regime - Van Cutsen, J; Tabernero, J; Lakomy, R; Prenen, H; Prausová, J; Macarulla, T (J Clin Oncol, 2012)